Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5)

Ji Hyun Park; Sang Hoon Chun; Yun Gyoo Lee; Hyun Chang; Keun Wook Lee; Hye Ryun Kim; Seong Hoon Shin; Ho Jung An; Kyoung Eun Lee; In Gyu Hwang; Myung Ju Ahn; Sung Bae Kim; Bhumsuk Keam

doi:10.1007/s00432-020-03342-3

Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5)

Ji Hyun Park
, Sang Hoon Chun
, Yun Gyoo Lee
, Hyun Chang
, Keun Wook Lee
, Hye Ryun Kim
, Seong Hoon Shin
, Ho Jung An
, Kyoung Eun Lee
, In Gyu Hwang
, Myung Ju Ahn
, Sung Bae Kim
, Bhumsuk Keam

Department of Internal Medicine

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

In the original article published, the first name of the author is incorrect. The correct author name is Ji Hyun Park.

Original language	English
Pages (from-to)	3371
Number of pages	1
Journal	Journal of Cancer Research and Clinical Oncology
Volume	146
Issue number	12
DOIs	https://doi.org/10.1007/s00432-020-03342-3
State	Published - Dec 2020

Bibliographical note

Publisher Copyright:
© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s00432-020-03342-3

Fingerprint

Dive into the research topics of 'Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5)'. Together they form a unique fingerprint.

Cite this

Park, J. H., Chun, S. H., Lee, Y. G., Chang, H., Lee, K. W., Kim, H. R., Shin, S. H., An, H. J., Lee, K. E., Hwang, I. G., Ahn, M. J., Kim, S. B., & Keam, B. (2020). Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5). Journal of Cancer Research and Clinical Oncology, 146(12), 3371. https://doi.org/10.1007/s00432-020-03342-3

Park, Ji Hyun ; Chun, Sang Hoon ; Lee, Yun Gyoo et al. / Correction to : Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5). In: Journal of Cancer Research and Clinical Oncology. 2020 ; Vol. 146, No. 12. pp. 3371.

@article{5b14b45e7e7a47c4826e0e3d433cc734,

title = "Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5)",

abstract = "In the original article published, the first name of the author is incorrect. The correct author name is Ji Hyun Park.",

author = "Park, \{Ji Hyun\} and Chun, \{Sang Hoon\} and Lee, \{Yun Gyoo\} and Hyun Chang and Lee, \{Keun Wook\} and Kim, \{Hye Ryun\} and Shin, \{Seong Hoon\} and An, \{Ho Jung\} and Lee, \{Kyoung Eun\} and Hwang, \{In Gyu\} and Ahn, \{Myung Ju\} and Kim, \{Sung Bae\} and Bhumsuk Keam",

note = "Publisher Copyright: {\textcopyright} 2020, Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2020",

month = dec,

doi = "10.1007/s00432-020-03342-3",

language = "English",

volume = "146",

pages = "3371",

journal = "Journal of Cancer Research and Clinical Oncology",

issn = "0171-5216",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "12",

}

Park, JH, Chun, SH, Lee, YG, Chang, H, Lee, KW, Kim, HR, Shin, SH, An, HJ, Lee, KE, Hwang, IG, Ahn, MJ, Kim, SB & Keam, B 2020, 'Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5)', Journal of Cancer Research and Clinical Oncology, vol. 146, no. 12, pp. 3371. https://doi.org/10.1007/s00432-020-03342-3

Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5). / Park, Ji Hyun; Chun, Sang Hoon; Lee, Yun Gyoo et al.
In: Journal of Cancer Research and Clinical Oncology, Vol. 146, No. 12, 12.2020, p. 3371.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5)

AU - Park, Ji Hyun

AU - Chun, Sang Hoon

AU - Lee, Yun Gyoo

AU - Chang, Hyun

AU - Lee, Keun Wook

AU - Kim, Hye Ryun

AU - Shin, Seong Hoon

AU - An, Ho Jung

AU - Lee, Kyoung Eun

AU - Hwang, In Gyu

AU - Ahn, Myung Ju

AU - Kim, Sung Bae

AU - Keam, Bhumsuk

PY - 2020/12

Y1 - 2020/12

N2 - In the original article published, the first name of the author is incorrect. The correct author name is Ji Hyun Park.

AB - In the original article published, the first name of the author is incorrect. The correct author name is Ji Hyun Park.

UR - https://www.scopus.com/pages/publications/85089909282

U2 - 10.1007/s00432-020-03342-3

DO - 10.1007/s00432-020-03342-3

M3 - Comment/debate

C2 - 32852636

AN - SCOPUS:85089909282

SN - 0171-5216

VL - 146

SP - 3371

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

IS - 12

ER -

Park JH, Chun SH, Lee YG, Chang H, Lee KW, Kim HR et al. Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 (Journal of Cancer Research and Clinical Oncology, (2020), 146, 12, (3359-3369), 10.1007/s00432-020-03316-5). Journal of Cancer Research and Clinical Oncology. 2020 Dec;146(12):3371. doi: 10.1007/s00432-020-03342-3